Latest filing published 16 Jun 2021 for Janux Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Bregua Corp: trading record in brief
This profile gathers the share dealings of Bregua Corp in Janux Therapeutics, Inc. Activity is concentrated on a single trading day, 15 June 2021, with 5 filings.
The open-market record is one-sided, with 1 purchase worth €825k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 16 June 2021, reports an open-market purchase of €825k in Janux Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Bregua Corp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,138,665 sharesCommon StockSEC:0001209191-21-041062:0
1 of 1 declaration
